Abstract: The present invention provides a deodorant composition which exhibits excellent and long-lasting deodorant effect against body odor, dries quickly on the skin, imparts soft feel to the skin, provides pleasant dry touch to the skin, and can be handled with ease. The deodorant composition contains a disinfectant or an antiperspirant and a thickener. The composition dries within a drying time of 30 seconds, has a dynamic friction resistance of 50% or less and a viscosity of 1,000-30,000 mPa·s.

Abstract: A bathing preparation is disclosed, comprising bathing agent components packed in a bag which is made of; a nonwoven or woven fabric consisting of a water soluble polymer fiber or a laminate sheet comprising a nonwoven or woven fabric consisting of a water soluble polymer fiber on the outside and a water soluble film on the inside.

Abstract: A patch is disclosed, which comprises a water-soluble adhesive sheet (a), and a patch is disclosed, which comprises a water-soluble adhesive sheet (a) and a water-soluble protective material (b) laminated thereon.This patch is convenient in handling and achieves high merit. Also, it can be applied to the skin so as to exhibit excellent warm-bathing effects on the application site.

Abstract: A vasodilating agent and a hair growth promoting agent comprising an extract of hypericum erectum thunb as an effective component are disclosed. The hypericum erectum thunb extract is prepared from ground leaf, stem, root, fruit, seed, or flower of hypericum erectum thunb by extraction with an organic solvent. It is effective for curing or preventing diseases caused by disorder in blood circulation such as hypertension, angina pectories, myocardial infarction, congestive heart failure, frostbite, chilblain, cold constitution, and alopecia.

Abstract: A vasodilating agent and a hair growth promoting agent comprising an extract of hypericum erectum thunb as an effective component are disclosed. The hypericum erectum thunb extract is prepared from ground leaf, stem, root, fruit, seed, or flower of hypericum erectum thunb by extraction with an organic solvent. It is effective for curing or preventing diseases caused by disorder in blood circulation such as hypertension, angina pectories, myocardial infarction, congestive heart failure, frostbite, chilblain, cold constitution, and alopecia.

Abstract: The closing plug and the closing plug device are used for closing a body defect percutaneously. During the insertion into the defect, the closing plug can be deformed to a smaller size to facilitate the insertion operation and recovered to its original larger shape after it is fitted to the defect, to thereby close the defect. The closing plug device facilitates the insertion of the closing plug into the defect. The closing plug has a flange or an enlarged portion at least at one end thereof and is made of a shape memory polymer having a shape recovery temperature in the range of 20.degree. C. to 70.degree. C. The closing plug device comprises a closing plug, a catheter and a guide wire or a pushing wire to aid in insertion of the closing plug to a defect.

Abstract: A percutaneous absorption accelerator and a percutaneous absorbent preparation containing the same and, more particularly, a percutaneous absorption accelerator containing either derivatives of specific glycerols or polyglycerols and alcohols as effective components and a percutaneous absorbent preparation containing the percutaneous absorption accelerators and pharmaceutically effective components.

Abstract: Novel external medications comprise, as essential components, the following three components (A) to (C):(A) an .alpha.-monoglyceryl ether represented by the following formula (I): ##STR1## wherein R means an alkyl or alkenyl group having 10 - 24 carbon atoms; (B) a physiologically active material; and(C) an oily material.The external medications have extremely high skin occlusive properties and significantly-improved absorptivity of phosiologically active materials. Therefore, a smaller amount of the medications compared with the conventional ones can give sufficient pharmacological effects and thus side effects can be reduced. The external medications may contain physiologically active materials such as drugs, growth hormones and the like, which are expected to show pharmacological effects upon their percutaneous absorption.

Abstract: A percutaneous absorption accelerator and a precutaneous absorbent preparation containing the same and, more particularly, a percutaneous absorption accelerator containing ether derivatives of specific glycerols or polyglycerols and alcohols as effective components and a percutaneous absorbent preparation containing the percutaneous absorption accelerators and pharmaceutically effective components.

Abstract: A medical composition for external application comprises a dialkyl phosphate represented by the formula: ##STR1## wherein R.sub.1 and R.sub.2 independently represent a hydrocarbon group having from 6 to 24 carbon atoms, R.sub.3 and R.sub.4 independently represent hydrocarbon group having from 2 to 6 carbon atoms, m and n independently represent a value of from 0 to 20, and x represents a hydrogen atom or a salt of an alkali metal and the like.In the presence of the dialkyl phosphate, percutaneous intake of medically active ingredients is highly enhanced. Examples of the medically active ingredients directed to in the invention include antiinflammatory agents such as ethyl aminobenzoate; adrenocortical hormones such as hydrocortisone; etc.The inventive composition is highly safe without giving any stimulation to the skin.